Patents by Inventor Takayuki Toshimitsu

Takayuki Toshimitsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058398
    Abstract: A subject is allowed to ingest a composition containing a lactic acid bacterium belonging to the genus Lactobacillus to improve inflammation in the brain tissue of the subject.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 22, 2024
    Applicant: MEIJI CO., LTD.
    Inventors: Asako SATO, Takayuki TOSHIMITSU
  • Publication number: 20230293605
    Abstract: The present invention relates to a composition for promoting the production of interleukin-10, the composition including: a lactic acid bacterium belonging to the genus Lactobacillus; and a fermented milk.
    Type: Application
    Filed: June 21, 2021
    Publication date: September 21, 2023
    Applicant: MEIJI CO., LTD.
    Inventors: Takayuki TOSHIMITSU, Yoshitaka KAWAI
  • Publication number: 20230058728
    Abstract: Provided is a composition for reducing heart rate, including a lactic acid bacterium belonging to the genus Lactobacillus. A subject is allowed to ingest a composition containing a lactic acid bacterium belonging to the genus Lactobacillus to reduce heart rate of the subject.
    Type: Application
    Filed: December 11, 2020
    Publication date: February 23, 2023
    Applicant: MEIJI CO., LTD.
    Inventors: Takayuki TOSHIMITSU, Toshihiro SASHIHARA, Yukio ASAMI
  • Patent number: 11173185
    Abstract: Provided is a method of producing a culture product of a microorganism, for obtaining a culture product excellent in anti-inflammatory property in which a ratio between the production amounts of IL-10 and IL-12 (ratio of IL-10/IL-12) is large. Specifically, provided is a method of producing a culture product of Lactobacillus plantarum, including culturing Lactobacillus plantarum using a medium containing an unsaturated fatty acid ester until a time point at or before an end of a logarithmic growth phase, to thereby obtain a culture product of Lactobacillus plantarum. The unsaturated fatty acid ester is an ester formed through a reaction between a monovalent or polyvalent unsaturated fatty acid and a polyhydric alcohol, or a derivative of the ester. A preferred example of the unsaturated fatty acid ester is a monooleic acid ester.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: November 16, 2021
    Assignee: MEIJI CO., LTD.
    Inventors: Keisuke Furuichi, Takayuki Toshimitsu, Satoru Ozaki
  • Publication number: 20200016221
    Abstract: Provided is a method of producing a culture product of a microorganism, for obtaining a culture product excellent in anti-inflammatory property in which a ratio between the production amounts of IL-10 and IL-12 (ratio of IL-10/IL-12) is large. Specifically, provided is a method of producing a culture product of Lactobacillus plantarum, including culturing Lactobacillus plantarum using a medium containing an unsaturated fatty acid ester until a time point at or before an end of a logarithmic growth phase, to thereby obtain a culture product of Lactobacillus plantarum. The unsaturated fatty acid ester is an ester formed through a reaction between a monovalent or polyvalent unsaturated fatty acid and a polyhydric alcohol, or a derivative of the ester. A preferred example of the unsaturated fatty acid ester is a monooleic acid ester.
    Type: Application
    Filed: August 18, 2017
    Publication date: January 16, 2020
    Inventors: Keisuke Furuichi, Takayuki Toshimitsu, Satoru Ozaki
  • Patent number: 9095604
    Abstract: The purpose of the present invention is to provide a probiotic(s) which can activate an aromatic hydrocarbon receptor (AhR) and can consequently prevent inflammatory damage in the digestive tract. The present invention relates to; a probiotic(s) capable of activating an AhR; an anti-inflammatory agent comprising the probiotic(s); an orally ingestible composition containing the anti-inflammatory agent; and a method for screening for the probiotic(s).
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: August 4, 2015
    Assignee: Meiji Co, Ltd.
    Inventors: Shuji Ikegami, Seiya Makino, Takayuki Toshimitsu, Hiroyuki Itoh, Atsuhito Nakao
  • Publication number: 20130302844
    Abstract: The purpose of the present invention is to provide a probiotic(s) which can activate an aromatic hydrocarbon receptor (AhR) and can consequently prevent inflammatory damage in the digestive tract. The present invention relates to; a probiotic(s) capable of activating an AhR; an anti-inflammatory agent comprising the probiotic(s); an orally ingestible composition containing the anti-inflammatory agent; and a method for screening for the probiotic(s).
    Type: Application
    Filed: September 8, 2011
    Publication date: November 14, 2013
    Applicant: Meiji Co., Ltd.
    Inventors: Shuji Ikegami, Seiya Makino, Takayuki Toshimitsu, Hiroyuki Itoh, Atsuhito Nakao